Julie Sheldon

7.5k total citations · 1 hit paper
110 papers, 4.9k citations indexed

About

Julie Sheldon is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Julie Sheldon has authored 110 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Epidemiology, 40 papers in Hepatology and 32 papers in Infectious Diseases. Recurrent topics in Julie Sheldon's work include Hepatitis C virus research (40 papers), Viral-associated cancers and disorders (28 papers) and Hepatitis B Virus Studies (28 papers). Julie Sheldon is often cited by papers focused on Hepatitis C virus research (40 papers), Viral-associated cancers and disorders (28 papers) and Hepatitis B Virus Studies (28 papers). Julie Sheldon collaborates with scholars based in United Kingdom, Germany and Spain. Julie Sheldon's co-authors include Celia Perales, Esteban Domingo, Thomas F. Schulz, Vincent Soriano, Berta Rodés, N. Soni, Giampaolo Merlini, Angeline Bartholomeusz, A. Myron Johnson and Julie Greensill and has published in prestigious journals such as New England Journal of Medicine, Blood and The Journal of Immunology.

In The Last Decade

Julie Sheldon

106 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Viral Quasispecies Evolution

2012 681 citations Julie Sheldon et al. profile →

Peers

Countries citing papers authored by Julie Sheldon

Since Specialization

Citations

This map shows the geographic impact of Julie Sheldon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Sheldon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Sheldon more than expected).

Fields of papers citing papers by Julie Sheldon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Sheldon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Sheldon. The network helps show where Julie Sheldon may publish in the future.

Co-authorship network of co-authors of Julie Sheldon

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Sheldon. A scholar is included among the top collaborators of Julie Sheldon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Sheldon. Julie Sheldon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services 2024 ·British Journal of Haematology ·Mark T. Drayson, (unknown), (unknown), Dina Patel, Guy Pratt, Suzanne Renwick, Alex Richter, Rachel D. Wheeler, Julie Sheldon, Ross Sadler, (unknown), Fenella Willis, (unknown)	1
2	Efficient acute and chronic infection of stem cell-derived hepatocytes by hepatitis C virus 2020 ·Gut ·Arnaud Carpentier, Julie Sheldon, Florian W. R. Vondran, Richard J. P. Brown, Thomas Pietschmann	15
3	Development of a Certified Reference Material for myeloperoxidase-anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA) 2016 ·Clinica Chimica Acta ·Evanthia Monogioudi, (unknown), Gustavo Martos, Julie Sheldon, Heinz Schimmel, Pier Luigi Meroni, Ingrid Zegers	14
4	Early-Pregnancy Multiple Serum Markers and Second-Trimester Uterine Artery Doppler in Predicting Preeclampsia 2010 ·Obstetrics and Gynecology ·B. Thilaganathan, Benjamin W. Wormald, (unknown), Julie Sheldon, Elizabeth Ralph, Aris T. Papageorghiou	58
5	401 FATIGUE IN CHRONIC HEPATITIS C INFECTION IS RELATED TO IMMUNE ACTIVATION AND ABNORMALITIES IN TRYPTOPHAN METABOLISM 2009 ·Journal of Hepatology ·Markus Gess, (unknown), (unknown), (unknown), Susan J. Clark, Matthew Cowan, Julie Sheldon, Daniel T. Holt, Daniel Forton	2
6	Raised Maternal Serum Cystatin C: An Early Pregnancy Marker for Preeclampsia 2009 ·Reproductive Sciences ·B. Thilaganathan, Elizabeth Ralph, Aris T. Papageorghiou, K. Melchiorre, Julie Sheldon	32
7	Indicaciones clínicas para los ensayos deproteínas plasmáticas: transtiretina(prealbúmina) en inflamación ydesnutrición 2008 ·Acta bioquímica clínica latinoamericana ·A. Myron Johnson, Giampaolo Merlini, Julie Sheldon, Kiyoshi Ichihara	3
8	Resistencias en el virus de la hepatitis B 2008 ·Enfermedades Infecciosas y Microbiología Clínica ·Julie Sheldon, Rui Castro, Vincent Soriano	2
9	Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): IFCC Scientific Division Committee on Plasma Proteins (C-PP) 2007 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·A. Myron Johnson, Giampaolo Merlini, Julie Sheldon, Kiyoshi Ichihara	144
10	Identification of a novel Haemophilus influenzae protein important for adhesion to epithelial cells 2007 ·Microbes and Infection ·Elena Ronander, Marta Brant, Håkan Janson, Julie Sheldon, Arne Forsgren, Kristian Riesbeck	37
11	Oxidized Low-Density Lipoprotein Autoantibodies, Chronic Infections, and Carotid Atherosclerosis in a Population-Based Study 2006 ·Journal of the American College of Cardiology ·Manuel Mayr, Stefan Kiechl, Sotirios Tsimikas, Elizabeth R. Miller, Julie Sheldon, Johann Willeit, Joseph L. Witztum, Qingbo Xu	59
12	Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection 2006 ·AIDS ·Guenther Schmutz, Mark Nelson, Thomas A. Lutz, Julie Sheldon, Raffaele Bruno, (unknown), Christian Hoffmann, Juergen Rockstroh, Albrecht Stoehr, Eva Wolf, Vincent Soriano, F. Berger, Thomas Berg, Amina Carlebach, Carolynne Schwarze‐Zander, Dirk Schürmann, Hans Jaeger, Stefan Mauss	66
13	Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy 2006 ·Journal of Antimicrobial Chemotherapy ·Berta Rodés, Julie Sheldon, Carlos Toro, Victoria Jiménez, (unknown), Vincent Soriano	68
14	IFN-γ at the Site of Infection Determines Rate of Clearance of Infection in Cryptococcal Meningitis 2005 ·The Journal of Immunology ·Asna A. Siddiqui, Annemarie E. Brouwer, (unknown), Shabbar Jaffar, Robin J. Shattock, (unknown), Julie Sheldon, Wirongrong Chierakul, Sharon J. Peacock, Nicholas Day, Nicholas J. White, Thomas S. Harrison	117
15	No Increased Human Herpesvirus 8 Seroprevalence in Patients With HIV-Associated Non-Hodgkin's Lymphoma 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), F. Agbalika, Julie Sheldon, Anne Maillard, Thomas F. Schulz, Éric Oksenhendler	12
16	Bone Marrow Failure Associated with Human Herpesvirus 8 Infection after Transplantation 2000 ·New England Journal of Medicine ·Mario Luppi, Patrizia Barozzi, Thomas F. Schulz, Gisella Setti, Katherine Staskus, Raffaella Trovato, Franco Narni, Amedea Donelli, Antonino Maiorana, Roberto Marasca, Silvio Sandrini, Giuseppe Torelli, Julie Sheldon	160
17	No evidence for a role of human herpesvirus type 8 in sarcoidosis: molecular and serological analysis 1999 ·British Journal of Dermatology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Julie Sheldon, Morel, (unknown), Thomas F. Schulz	18
18	Human herpes-virus 8 seropositive patient with skin and graft Kaposi’s sarcoma after lung transplantation 1999 ·Journal of the American Academy of Dermatology ·(unknown), (unknown), Julie Sheldon, Thomas F. Schulz, Marc Péchère, Roland G. Nádor, Anastase Spiliopoulos, Laurent Nicod, Jean‐Hilaire Saurat	33
19	Transient Angiolymphoid Hyperplasia and Kaposi's Sarcoma after Primary Infection with Human Herpesvirus 8 in a Patient with Human Immunodeficiency Virus Infection 1998 ·New England Journal of Medicine ·Éric Oksenhendler, Dominique Cazals‐Hatem, Thomas F. Schulz, Véronique Barateau, L Grollet, Julie Sheldon, Jean‐Pierre Clauvel, François Sigaux, F. Agbalika	77
20	Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents 1998 ·International Journal of Cancer ·(unknown), Luís E. Cuevas, Julie Sheldon, (unknown), David H. Smith, Pius Okong, (unknown), C. Anthony Hart, Thomas F. Schulz	224

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact